BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Loading...
Loading...

Hct116 Cells Pages on BioPortfolio:

BioPortfolio Biotechnology BioNews : live article
"Flow cytometric studies and fluorescence microscopy indicate that in PDT-treated HCT116 cells death occurs mainly by apoptosis. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - KYODO CHEMICAL COMPANY
Biotechnology News MEDROXYPROGESTERONE ACETATE mpa. hct116. g0g1 . ... Erythrophagocytosis by Liver Macrophages (Kupffer Cells) Promotes . ...
http://www.bioportfolio.com/search/_KYODO_CHEMICAL_COMPANY_....

BioPortfolio Biotechnology BioNews : live article
Targeted inactivation of Bax or p53 in HCT116 cells resulted in significantly increased resistance to oxaliplatin. However, the mutational status of p53 was ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Biotechnology, Pharmaceutical and Life Science Email addresses for ...
Stem Cells · Leukaemia Researchers ... Academic scientific researchers working in the fields of immunology, cell biology, stem cells and neuroscience ...
http://www.bioportfolio.com/advertis/bioemail.htm...

Results from other life science and pharmaceutical sites:

Transfecting Plasmid DNA into HCT-116 Cells Using Lipofectamine ...
DNA into HCT-116, human colon carcinoma cells (ATCC no. ... Follow these important guidelines when transfecting HCT-116 cells using Lipofectamine LTX ...
http://www.invitrogen.com/etc/medialib/en/filelibrary/pdf/pr...

Lapatinib resistance in HCT116 cells is mediated b...[Mol ...
Prolonged incubation of HCT116 cells with Lapatinib caused cell killing followed by ... Thus in HCT116 cells Lapatinib adaptation can be mediated by altered ...
http://www.ncbi.nlm.nih.gov/pubmed/18544666...

Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to ...
For comparison, HCT-116 cells lacking p53 function were also prepared through ... HCT-116 cells with disrupted p21 genes also exhibited greater CDDP and ...
http://www.nature.com/onc/journal/v14/n18/abs/1201052a.html...

Photodynamic therapy-induced death of HCT 116 cell...[Apoptosis ...
Photodynamic therapy-induced death of HCT 116 cells: Apoptosis with or ... Cell death following photodynamic therapy (PDT) with the photosensitizer Pc 4 ...
http://www.ncbi.nlm.nih.gov/pubmed/16215676...

Microsoft PowerPoint - AACR2005 Poster TopoTarget UK LTD Final ...
Incubation of the HCT116 cell line (an established model of. colon cancer) ... of HCT116 cells treated for 24 hours +/- PXD101 followed by ...
http://www.curagen.com/uploaded_files/AACR20_1.PDF...

hRFI overexpressed in HCT116 cells modulates Bcl-2...[Oncol Rep ...
As a result, we identified four genes (Bcl-2, Bcl-XL, cIAP2, and CFLAR) whose expression was four or more times higher in HCT116/ hRFI cells than in ...
http://www.ncbi.nlm.nih.gov/pubmed/16596200?dopt=Abstract...

DNMT1 knockout delivers a strong blow to genome stability and cell ...
HCT116 cells deficient in DNMT1 have proven extremely useful and have been used ... DNMT1 knockout in HCT116 cells activates G2 arrest; however, these cells ...
http://www.nature.com/ng/journal/v39/n3/full/ng0307-289.html...

Apoptosis induction in HCT116 cells by cytochalasi ...
These apoptotic activities were stronger than that of cytochalasin D as a known apoptosis inducer in HCT116 cell. However, cc4 and cc12 induced necrosis. ...
http://www.ncbi.nlm.nih.gov/pubmed/10715842...

In vitro hypoxia-conditioned colon cancer cell lines derived from ...
The colon carcinoma cell lines HT29 and HCT116 were subjected to 40 episodes of sublethal ..... HCT116 cells in which p53 was knocked out became resistant. ...
http://www.nature.com/bjc/journal/v93/n12/full/6602864a.html...

FAT10, a gene up-regulated in various cancers, is cell-cycle regulated
(A) Cell-cycle profiles of HCT116 cells synchronized at the various .... Western blot analyses was performed on HCT116 cell lysates (7 μg/well) (Lee et al., ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15...

Google Custom Search

Search
  

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo